Search

DNA damage from chemotherapy can activate cGAS–STING and interferon pathways. Here, the authors show that cGAS–STING signaling is specific to DNA rich in CA repeats, whereas DNA not rich in CA repeats is detected by AIM2, resulting in opposing tumor immune responses.

Viruses such as EBV use various mechanisms to avoid antiviral responses. Here the authors propose that the EBV protein BRRF2 is secreted via extracellular vesicles from NPC cells, disrupts the cGAS-STING pathway, reduces cGAS-DNA phase separation and the subsequent antiviral response.

Oxaloacetate is sensed by MDH1, which primes innate immune antiviral defence against influenza virus infection, thus resulting in the activation of ETS2 to promote TBK1-centred type I interferon signalling.

Targeting tumors with c-MYC dysregulation is very challenging due to low MYC expression and intratumor heterogeneity. Here, the authors report a MYC-based gene circuitry that enhances immunotherapy response and tumor killing in bladder cancer.

Mutual paracrine regulation of the cytokines GREM1 and SPP1 mediate mesenchymal and epithelial cell fate in pancreatic cancer.

Yin, Lin, Cai, Nie and colleagues report phase separation of ERCC6L2 as a mechanism that regulates RNF138-mediated ubiquitination and degradation of CtIP, thereby modulating DNA end resection and treatment response to ATM inhibitors in cancer.

Li and colleagues report that a septo-enteric polysynaptic circuit that is activated by chronic stress links the brain to the tumor microenvironment to promote colorectal cancer growth.

Zhang, Huang, Wang, Long et al. report that NAT10 enhances serine uptake and biosynthesis in an ac4C-dependent mechanism, thereby promoting stemness and progression in acute myeloid leukaemia.

This study shows that Galectin-3 promotes wound healing by binding to and undergoing phase separation with integrin α5β1, a process disrupted by AGEs in pre-clinical models of diabetes. Topical Galectin-3 restored healing in synergy with insulin.

Two phase 2 trials, along with translational analysis of prospective cohorts and experimental analysis, indicate that immunosenescence as a mechanism of resistance to immunotherapy can be overcome with the senolytics dasatinib and quercetin in patients with head and neck squamous cell carcinoma.

Flexible alternating-current electroluminescent devices have potential in a range of applications, but improving electrical properties can require loss of transparency. Here, the authors report a printable, high-dielectric, transparent ink, to allow efficient light transmission.

Hu et al. identify border-associated macrophages as early targets of brain aging. These cells acquire senescence-associated properties, which are transmittable via migrasomes carrying the apoptosis inhibitor of macrophage. Blocking migrasome production attenuates cognitive decline in aged mice.

Epstein–Barr virus - host chromatin interactions in nasopharyngeal carcinoma remain poorly understood. Here, the authors characterise the virus‒host chromatin interactions leading to genome reorganisation and identify a KDM5B-relevant signature associated with distant metastasis.

Protein C receptor (PROCR) has been proposed as a cancer stem cell marker in different types of cancer. Here the authors report that PROCR upregulation in cancer cells is associated with resistance to radiotherapy and reduced anti-tumour immunity.

The diagnosis and prognosis of chronic kidney disease (CKD) relies on invasive renal biopsies, which can be clinically constrained. Here, the authors develop a non-invasive model using retinal images that can be used to screen for CKD and identify five common pathological types of CKD.

A magnetically steered flexible bioelectronic catheter enables minimally invasive surgeries in animal models with simultaneous metabolite sensing.

Bi, Mo, Liu et al. carry out high-throughput screening and analysis to profile genome-wide pro-tumour enhancers and uncover enhancer connectomes in glioma. In particular, they identify specific single-nucleotide polymorphisms associated with glioma risk and progression.

Trained and validated on multimodal data from 14.5 million images from multicountry datasets, a foundation model is shown to increase diagnostic and referral accuracy of clinicians when used as an assistant in a trial involving 16 ophthalmologists and 668 patients.

R9AP is a key receptor for entry of Epstein–Barr virus into human epithelial and B cells, and interacts directly with the viral glycoprotein gH/gL complex to mediate virus–host membrane fusion.

Lithium doping in spiro-OMeTAD negatively affects the long-term performance of perovskite solar cells. Qin and team map the degradation mechanism under repeated voltage cycling and how lithium-free dopants improve stability.

Interpreting bone metastases (BMs) from computed tomography (CT) images remains challenging. Here, the authors develop an AI-based Bone Lesion Detection System - BLDS - and validate it in a cohort of 2,518 patients across five hospitals, showing highly sensitive and accurate performance for BM detection from CT scans.

ctDNA is a promising method to monitor tumor burden in triple negative breast cancer. Here, the authors show that ctDNA detection correlated with prognosis after neoadjuvant chemotherapy but not at baseline.

Influenza A virus neuraminidase (NA) is an important target for universal influenza vaccines. Here, the authors identify two monoclonal antibodies, CAV-F6 and CAV-F34, that inhibit NA activity across multiple subtypes, offering protection against seasonal and emerging avian influenza strains, thus advancing the development of broadly protective vaccines and therapeutics.

Untargeted metabolomic analysis provides comprehensive metabolic profiling but faces challenges in medical application. Here, the authors present an explainable deep learning method for end-to-end analysis on raw metabolic signals to differentiate metabolomic profiles of cancers with high accuracy.

Androgen receptor (AR) usually drives prostate cancer cell growth, but its role in immune cells like macrophages, remains unclear. The authors here show that AR⁺TREM2⁺ macrophages exhibits enhanced immunosuppressive and tumour-promoting effects comping to its counterparts with the mechanism of upregulated APOE/TREM2/AR expression in inducing immunosuppressive gene profile in macrophage.

Radiation-induced mucositis significantly reduces patient quality of life. Here, the authors report on inorganic-free nanosheets that selectively capture inflammatory small extracellular vesicles, reducing oxidative stress, restoring immune balance and reducing radiation-induced mucositis.

Li et al. demonstrate mitochondrial fission in macrophages as key for phagocytosis induced by therapeutic antibodies. They identify overexpression of GFPT2 as an inhibitor of the process and phase transition of the phagocytic machinery as its regulator.

Metabolic reprogramming can induce a susceptible metabolic state in carbapenem- and extended-spectrum β-lactamase-resistant bacterial pathogens, thereby enhancing their sensitivity to antibiotics.

Ductal lavage represents a treatment option for idiopathic granulomatous mastitis. Here, the authors report the results of a randomized clinical trial, indicating that ductal lavage followed by observation is non-inferior to oral corticosteroids

Achieving fairness while preserving privacy in medical imaging tasks remains a significant challenge. Here, the authors present and comprehensively evaluate a federated learning framework to tackle both fairness and privacy issues, using a flexible regularization term to integrate multiple fairness criteria.

Stromal cells in the tumour microenvironment are reported to regulate cancer stemness via biomechanical signals. Here the authors show that TAZ activated by biomechanical cues enhanced cancer stem cell properties via phase separation with Nanog.

Extracellular vesicles (EVs) can provide critical information for diagnostics, but analysis can be difficult. Here, the authors develop a super-resolution imaging method that combines rolling circle amplification with expansion microscopy to reveal surface/internal markers in single EVs for cancer diagnosis and immunotherapy prediction.

Cancer cells downregulate surface expression of major histocompatibility complex I (MHC-I) for immune evasion. Here, the authors show that rapid mitochondrial fission activates the ER-stress response leading to reduced MHC-I complex formation and cell surface expression in solid cancer cells; moreover inhibition of mitochondrial fission increases the immune-mediated anticancer response in murine models.

Pancreatic β-cell dysfunction leads to insulin deficiency in both type 1 and type 2 diabetes. Here, the authors show that enhancing MARCH5 or inhibiting TRIM28 boosts insulin production by stabilizing Kindlin-2 and MafA.

Epstein-Barr virus is associated with increased cancer risk. Here, the authors analysed two population-based prospective cohorts in Southern China to examine the association between increased seropositivity and the risk of multiple cancer types.

A self-floating photocatalytic film enables rapid bacterial inactivation under weak natural sunlight.

Here the authors reveal a study of 486,956 Han Chinese individuals showing that most people with genetic variants affecting drug response do not have the predicted adverse events, highlighting the challenges of implementing pharmacogenetics in clinical practice.

Prostate cancer is heterogenous in response to therapy. Here, the authors analyse genomics, transcriptomics, proteomics and phosphoproteomics data from 145 prostate cancer patients to identify NANS as a therapeutic target in prostate cancer.

Alpha-fetoprotein is a known biomarker for hepatocellular carcinoma. Here, the authors analyse differences between AFP positive and negative patients to identify alterations in androgen receptor signalling.

Nie et al. show that myocardial CCDC25 detects doxorubicin-induced neutrophil extracellular trap DNA and activates reactive oxygen species production and autophagy, leading to cardiotoxicity. Targeting CCDC25 exerts a cardioprotective effect without impacting the antitumor activity of doxorubicin in lymphoma and breast cancer models.

Lactylation of NBS1 by TIP60 promotes homologous recombination-driven DNA repair and resistance to chemotherapy in cancer cells and links altered cancer cell metabolism to increase genome stability.

Oncogenic KRAS mutations can dictate the formation of an immune-suppressive tumor microenvironment. Here the authors report that, in KRAS mutant colorectal cancer, the upregulation of circATXN7 in tumor-specific cytotoxic T lymphocytes is associated with increased sensitivity to activation-induced cell death and resistance to immunotherapy.”

Extracting high-purity salt from saline water through conventional processes is complex and environmentally unsustainable. A diffusion-driven selective crystallization strategy that uses a precisely designed floating porous membrane to suppress non-ion-selective transfer enables simple and precise ion separation and high-purity salt production from mixed source solutions such as Na⁺/K⁺, Ba²⁺/K⁺ and Mg²⁺/Li⁺.

Current prognostic biomarkers for colorectal cancer (CRC) tend to lack generalisability across different cohorts and platforms. Here, the authors introduce PIANOS, a classifier for stratifying CRC patients into distinct risk groups across different platforms and cohorts, which allows predicting clinical outcomes and therapies.

SAT1 is a rate-limiting enzyme in polyamine catabolism. Here, authors discover a non-canonical function of SAT1 regulating H3K27ac marks within genes required for mitosis regulation and chromosome segregation, enabling anchorage-independent cell survival and peritoneal metastasis of ovarian cancer cells.

Neoadjuvant cancer therapeutic strategy has been explored in phase I/II clinical studies for head and neck squamous cell carcinoma. Here this group reports a single-arm, phase II clinical trial evaluating the neoadjuvant radiotherapy plus PD-1 inhibitor tislelizumab combined with paclitaxel and cisplatin, followed by radical surgical resection on 28 patients with untreated stage III-IVB head and neck squamous cell carcinoma.